glp 1 osteoarthritis GLP-1 and Inflammation: How These Drugs Ease Arthritis The Five-Year Incidence of Progression

This week, we dive into GLP-1 therapies showing dual benefits for psoriasis and atopic dermatitis, risankizumab proving highly effective in treating difficult areas affected by psoriasis, and new data on UVB + tofacitinib and afamelanotide in vitiligo

However, the cardiovascular outcome trials that have been completed so far have failed to show cardioprotection with DPP-4 inhibitor treatment, which might be partly attributable to limitations of the study design, patient selection and trial duration

Crosstalk between glucagon-like peptide 1 and gut microbiota in metabolic diseases

The scope encompasses cadmium-induced hepatotoxicity, the exacerbating effects of co-exposures such as microplastics, and the protective roles of agents including luteolin and fermented Chinese herbal medicine (FCHM)

Both of these groups exhibited increased stiffness in comparison to the control, however, the difference was not statistically significant